Monthly Archives: June 2011

$MSB.AX, no thanks. I’d rather have miso-soup

Posted on June 20, 2011 by BioChef in Training

I wasn’t planning to post another stem cell article so soon after my quick peak into the neural stem cell space, but when I saw that Mesoblast ($MSB.AX), an Aussie-based stem cell company, had a market cap of A$2.4B, or … Continue reading →

Posted in I don't get it | Tagged , , , , , , , , , | 1 Comment

Full steam ahead for $AVEO

Posted on June 15, 2011 by BioChef in Training

$AVEO is raising cash…surprised? Not really. It was matter of necessity. I first wrote about them in an post last month and thought that a financing was coming, though I thought they would take advantage of a somewhat slower summer … Continue reading →

Posted in Spinning wheels | Tagged , , , | Leave a comment

Expect the unexpected

Posted on June 13, 2011 by BioChef in Training

In biotech, always expect the unexpected. Over the past 9-mo, Savient Pharmaceuticals ($SVNT) has seen its market cap explode to $1.6B with Krystexxa (pegloticase) approval for treatment refractory gout, only to see its value fall past its pre-approval valuation of … Continue reading →

Posted in Up and Down | Tagged , , , | Leave a comment

No ASCO news here, just new oldies

Posted on June 4, 2011 by BioChef in Training

Thumbs-up to the bloggers who post regularly. It is not as easy as it appears, especially after holidays – good thing I decided to get a degree in the biological sciences instead (?!). Hard to believe, but ASCO has arrived. … Continue reading →

Posted in Old drugs made new | Tagged , , , , | Leave a comment